Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Report 2024: Comprehensive Insight on All Drugs in the Clinical Pipeline by Company, Indication & Phase
February 29, 2024 04:05 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities
February 16, 2024 04:09 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market...
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
February 01, 2024 03:16 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Overview of SAb Biotherapeutics' Drug SAB-176: Phase IIb Trial Insights, SWOT Analysis, and Market Forecast to 2032
January 30, 2024 05:31 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "SAB-176 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a...
Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research
January 30, 2024 05:20 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
Analysis of DNAtrix's Drug DNX-2401, 2023 to 2032: A Promising Candidate for Glioblastoma Multiforme (GBM) Treatment
January 30, 2024 05:01 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "DNX-2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical industry...
TC-210 Drug and Market Report 2023-2032: Revolutionizing the Malignant Pleural Mesothelioma (MPM) Treatment Landscape
January 29, 2024 13:09 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TC-210 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The clinical landscape of...
Africa Pharmaceutical Regulatory Affairs Analysis Report 2023
January 24, 2024 10:14 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Africa Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Indication, By Product Stage, By...
SM04690 for Osteoarthritis: Emerging Drug Insight and Market Forecasts to 2032 - Focus on 6 Major Markets
January 24, 2024 08:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SM04690 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "SM04690 Emerging Drug...
Emerging Trends in the Orphan Drugs Industry, 2023-2028: Worldwide Market Analysis Featuring Profiles of Leading Players AstraZeneca, Eisai, Bristol Myers Squibb, and Pfizer Among Others
January 17, 2024 10:03 ET
|
Research and Markets
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The global orphan drugs market was valued at an...